Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Traws Pharma, Inc. (TRAW) had Normalized Pre-Tax Income of $-0.92M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.73M |
|
$-0.62M |
|
-- |
|
$2.73M |
|
$3.98M |
|
$-1.25M |
|
$0.33M |
|
$-0.92M |
|
|
Normalized Pre-Tax Income |
$-0.92M |
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-1.25M |
|
$-1.25M |
|
5.82M |
|
5.82M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$15.37M |
|
$0.01M |
|
$0.25M |
|
$15.62M |
|
$7.35M |
|
-- |
|
$0.01M |
|
$7.36M |
|
$8.26M |
|
$8.26M |
|
$8.26M |
|
7.07M |
|
| Cash Flow Statement Financials | |
$-11.42M |
|
$0.00M |
|
$3.11M |
|
$21.34M |
|
$13.08M |
|
$-8.26M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-45.70% |
|
-45.70% |
|
-- |
|
-33.48% |
|
-22.87% |
|
$-11.42M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
2.07 |
|
43.57 |
|
-11.07% |
|
-11.07% |
|
-5.86% |
|
-11.07% |
|
$1.17 |
|
$-1.96 |
|
$-1.96 |
|